Inofib

Saint-martin-d'heres, France Founded: 2009 • Age: 17 yrs
A technology for nanocellulose production from wood is developed.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About Inofib

Inofib is a company based in Saint-martin-d'heres (France) founded in 2009. Inofib offers products and services including ERP Retail and Rideau Lamelle Plastique. Inofib operates in a competitive market with competitors including Sigachi, Matrix Food Technologies, Gelatex, FineCell and ANPOLY, among others.

  • Headquarter Saint-martin-d'heres, France
  • Sectors
    Technology
    Chemicals & Materials
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Technology → Quantum & Emerging Technologies
Chemicals & Materials → Advanced & Functional Materials
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $326.5 K (USD), Grant

    Oct 01, 2016

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Inofib

Inofib offers a comprehensive portfolio of products and services, including ERP Retail and Rideau Lamelle Plastique.

Primary

System for optimizing retail operations and management processes.

Plastic curtain for industrial temperature control and protection.

Funding Insights of Inofib

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $326,501
  • First Round

    (10 Jan 2016)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2016 Amount Grant - Inofib Valuation

investors

Jan, 2016 Amount Grant - Inofib Valuation

investors

Investors in Inofib

Inofib has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location

Investments & Acquisitions by Inofib

Investments

Financial Statements - Inofib

Inofib Comparisons

+
Add Comparison
Available on Premium

Competitors of Inofib

Inofib operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sigachi, Matrix Food Technologies, Gelatex, FineCell and ANPOLY, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Manufacturer of microcrystalline cellulose
domain founded_year HQ Location
Plant-based meat alternatives are manufactured without animal components.
domain founded_year HQ Location
Gelatin nanofibers are developed for textile applications by Gelatex.
domain founded_year HQ Location
Nanocellulose products are developed for industrial applications.
domain founded_year HQ Location
Cellulose and chitin nanofibers are supplied for research applications.
domain founded_year HQ Location
Developer of biopolymers and nanoparticles based on chitin and chitosan

Latest news on Inofib

Frequently Asked Questions about Inofib

Inofib was founded in 2009 and raised its 1st funding round 7 years after it was founded.

Inofib is headquartered in Saint-martin-d'heres, France. It is registered at Saint-martin-d'heres, Auvergne-rhone-alpes, France.

Karim Missoum is the current CEO of Inofib.

Inofib was founded in 2009 to advance technology for nanocellulose manufacturing from wood. Operations center on the biotechnology and sustainable materials sector, where processes are refined to extract and produce nanocellulose for industrial applications. Leadership is held by CEO Karim Missoum. The company is based in France, with activities directed toward scalable production methods using renewable wood resources. No specific services beyond technology development are detailed.

Inofib's top competitors include Sigachi, Matrix Food Technologies and ANPOLY.

Inofib offers ERP Retail and Rideau Lamelle Plastique.

Inofib has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available